Standard BioTools Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Standard BioTools stock has a consensus rating of "Buy" and an average price target of $1.55. The average 1-year stock price forecast is 86.81% higher than the current stock price, while the lowest is $1.35 (+62.71%) and the highest is $1.75 (+110.92%).

Price Target: $1.55 (+86.81%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.35	$1.55	$1.55	$1.75
Change	+62.71%	+86.81%	+86.81%	+110.92%

* Price targets were last updated on May 6, 2026.

Analyst Ratings

The average analyst rating for Standard BioTools stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	2	2	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kyle Boucher TD Cowen	TD Cowen	Hold Maintains $1.35	Hold	Maintains	$1.35	+62.71%	May 6, 2026
Paul Knight KeyBanc	KeyBanc	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Feb 25, 2026

Financial Forecast

Revenue This Year

82.50M

from 85.33M

-3.32%

from 85.33M

Revenue Next Year

84.10M

from 82.50M

1.94%

from 82.50M

EPS This Year

0.03

from -0.14

EPS Next Year

-0.01

from 0.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	130.58M	97.95M	106.34M	91.01M	85.33M	82.50M
Revenue Growth	-5.48%	-24.99%	8.57%	-14.42%	-6.24%	-3.32%
Gross Profit	31.43M	37.05M	50.45M	44.88M	42.54M	44.39M
Gross Margin	24.07%	37.83%	47.44%	49.32%	49.86%	53.80%
Operating Income	-67.46M	-99.09M	-63.04M	-87.01M	-93.31M	-36.20M
Net Income	-59.24M	-190.10M	-74.66M	-138.89M	-74.90M	-38.80M
EPS	-	-	-	-	-0.14	0.03
Forward PE	-	-	-	-	-	27.66
Free Cash Flow	-31.59M	-39.97M	-9.27M	-54.61M	-171.83M	-4.00M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	82.5M
Avg	82.5M
Low	82.5M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-3.3%
Avg	-3.3%
Low	-3.3%

EPS Forecast

EPS	2026	2027	2028
High	0.03
Avg	0.03
Low	0.03

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-